About OlaWell
OlaWell was a Healthcare company based in United States founded in 2018. It develops innovative technologies for gut microbiome testing platforms. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Diagnostic Testing and Microbiome Analysis. Its competitors include Viome, Seed, Azitra, Flore and Evvy and 5 more; 10 of its 10 listed competitors have raised funding.
Company details
OlaWell develops innovative technologies for gut microbiome testing platforms, focusing on providing healthcare solutions, advancing biotech innovations, diagnostic testing, and microbiome analysis. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters United States
- SectorsHealthcare
- Website olawell.com
- Social X Facebook
Competitors of OlaWell
OlaWell has 10 listed competitors in our database, 10 of them funded. They include Viome, Seed, Azitra, Flore and Evvy, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viome.com | 2016 | Los Alamos, United States | $301.57M | 136 | Machine learning-based bioinformatics solutions for health insights are provided. | |
| seed.com | 2016 | Los Angeles, United States | $40.62M | – | Synbiotics are developed for simulating the gut microbiome. | |
| azitrainc.com | 2014 | Farmington, United States | $37.4M | 17 | Microbiome-based therapeutics for skin conditions like eczema are developed. | |
| flore.com | 2016 | San Diego, United States | $21.12M | – | Customized probiotics for gut health are provided via stool analysis. | |
| evvy.com | 2002 | New York, United States | $19M | 9 | Vaginal microbiome test kits are provided through an online platform. | |
| biomesense.com | 2018 | Chicago, United States | $8.43M | 9 | AI-enabled platform for microbiome data generation and analysis is developed. | |
| holobiome.org | 2015 | Cambridge, United States | $15.59M | – | Microbiome-based therapeutics for nervous system disorders are developed. | |
| ubiome.com | 2012 | San Francisco, United States | $109.62M | 33 | Provides comprehensive sequence datasets for human microbiome research and analysis. | |
| ixcela.com | 2012 | Bedford, United States | $7.99M | – | Developer of online platform and microbiome health monitoring test kit | |
| nakedbiome.com | 2015 | San Francisco, United States | $7.76M | – | Develops genomics tools for treating skin diseases through microbiome research and therapeutics. |
Detailed competitors of OlaWell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Microbiome Therapeutics
10 companies that operate in the same segment as OlaWell (Microbiome Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Biosolutions and enzymes are developed for biotechnology applications across industries. | 2000 | Bags Sword, Denmark | – | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Gut microbiome insights, analytics, tests, and therapeutics are provided. | 2019 | Singapore, Singapore | USD 10.5 M | USD 1.37 M | – | |
Microbiome-based therapeutics for skin conditions like eczema are developed. | 2014 | Farmington, United States | USD 37.4 M | – | 12 | |
Engineered microbes are developed as programmable therapeutics for metabolic disorders. | 2013 | Cambridge, Massachusetts, United States | USD 34.4 M | USD 8 K | 1 | |
Therapeutics for infectious and autoimmune diseases are developed. | 2010 | Cambridge, Massachusetts, United States | USD 470.49 M | – | 71 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Microbiome-based therapeutics for gut diseases are developed. | 2017 | Edinburgh, Scotland, United Kingdom | USD 72.96 M | – | 65 | |
The gut-brain axis is explored for therapeutic and nutritional innovations. | 2014 | New York, New York, United States | USD 479 M | – | 84 | |
Microbiome therapeutics are developed to address diverse diseases. | 2010 | Cambridge, Massachusetts, United States | USD 257.13 M | USD 789 K | 103 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about OlaWell
OlaWell was founded in 2018.
OlaWell is headquartered in United States.
OlaWell develops innovative technologies for gut microbiome testing platforms, focusing on providing healthcare solutions, advancing biotech innovations, diagnostic testing, and microbiome analysis. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.